Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prospective alpha allocation in the Clarification of Optimal Anticoagulation through Genetics (COAG) trial.

Clinical trials (London, England) - 1 Oct 2010

Joo Jungnam, Geller Nancy L, French Benjamin, Kimmel Stephen E, Rosenberg Yves, Ellenberg Jonas H

Abstract excerpt

BACKGROUND: The Clarification of Optimal Anticoagulation through Genetics (COAG) trial is a large, multicenter, double-blinded, randomized trial to determine whether use of a genotype-guided dosing algorithm (using clinical and genetic information) to initiate warfarin treatment will improve anti...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Drug Dosage Calculations
Share to Patient Selection

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Randomized Controlled Trials as Topic

Share to Research Design

Share to Statistics as Topic

Share to Warfarin

Source

Open in PubMed Open full text

Identifiers

PMID: 20693186
DOI: 10.1177/1740774510381285
PMCID: PMC3111931

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20693186-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prospective alpha allocation in the Clarification of Optimal Anticoagulation through Genetics (COAG) trial.PMID 20693186Read ↗

Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trial.Semantic proximity Read ↗

Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial.Semantic proximity Read ↗

Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials.Semantic proximity Read ↗

Warfarin Dosing According to the Genotype-guided Algorithm is Most Beneficial in Patients With Atrial Fibrillation: A Randomized Parallel Group Trial.Semantic proximity Read ↗

Subgroup analysis of genotype guided vs traditional warfarin dosing in Asian patients from an open label randomized trial.Semantic proximity Read ↗

Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials.Semantic proximity Read ↗

Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials.Semantic proximity Read ↗

A pharmacogenetic versus a clinical algorithm for warfarin dosing.Semantic proximity Read ↗

Meta-analysis of randomized controlled trials reveals an improved clinical outcome of using genotype plus clinical algorithm for warfarin dosing.Semantic proximity Read ↗

Efficacy and safety of genotype-guided warfarin dosing versus non-genotype-guided warfarin dosing strategies: A systematic review and meta-analysis of 27 randomized controlled trials.Semantic proximity Read ↗

Warfarin pharmacogenetics: to genotype or not to genotype, that is the question.Semantic proximity Read ↗

Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.